[go: up one dir, main page]

CN103529202B - A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells - Google Patents

A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells Download PDF

Info

Publication number
CN103529202B
CN103529202B CN201310419228.XA CN201310419228A CN103529202B CN 103529202 B CN103529202 B CN 103529202B CN 201310419228 A CN201310419228 A CN 201310419228A CN 103529202 B CN103529202 B CN 103529202B
Authority
CN
China
Prior art keywords
cells
cell
wild
sorting
gate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310419228.XA
Other languages
Chinese (zh)
Other versions
CN103529202A (en
Inventor
许安
王希楠
陈少鹏
吴李君
黑国庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hefei Institutes of Physical Science of CAS
Original Assignee
Hefei Institutes of Physical Science of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hefei Institutes of Physical Science of CAS filed Critical Hefei Institutes of Physical Science of CAS
Priority to CN201310419228.XA priority Critical patent/CN103529202B/en
Publication of CN103529202A publication Critical patent/CN103529202A/en
Application granted granted Critical
Publication of CN103529202B publication Critical patent/CN103529202B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/34Purifying; Cleaning
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明公开了一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法,包括野生型细胞收集;与荧光抗体的结合;制备上样悬液;细胞分选;保存。该方法操作简单,从收集细胞、与特异性荧光蛋白结合到分选,整个过程仅需4-5小时,并可同时获得能连续培养的未突变(CD59+)细胞和突变(CD59-)细胞,这在很大程度上提高CD59基因突变检测的效率。通过该方法,AL细胞的自发突变率可降至105存活细胞中约有30个突变细胞,较Panning后获得的自发突变下降2倍,有效提高了该突变检测系统的实验灵敏性。

The invention discloses a method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells, which comprises the steps of collecting wild-type cells; combining with fluorescent antibodies; preparing sample suspension; cell sorting; and preserving. The method is simple to operate, and the whole process from collecting cells, combining with specific fluorescent proteins to sorting, only takes 4-5 hours, and can simultaneously obtain unmutated (CD59 + ) cells and mutant (CD59 - ) cells that can be continuously cultured , which greatly improves the efficiency of CD59 gene mutation detection. Through this method, the spontaneous mutation rate of AL cells can be reduced to about 30 mutant cells in 10 5 surviving cells, which is 2 times lower than the spontaneous mutation obtained after Panning, which effectively improves the experimental sensitivity of the mutation detection system.

Description

一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells

技术领域 technical field

本发明涉及一种哺乳动物细胞突变检测技术领域,尤其涉及的是一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法。 The invention relates to the technical field of mammalian cell mutation detection, in particular to a method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells.

背景技术 Background technique

基因突变不仅是癌症发生的关键因素之一,而且是环境污染物遗传毒性评价的重要依据。AL细胞是中国仓鼠CHO细胞gly-A突变株与正常人成纤维细胞杂交后所得永生化细胞,含有一整套中国仓鼠CHO-K1染色体和一条人的11号染色体。人的11号染色体可编码多种细胞表面蛋白,其中包括CD59基因(旧称为MIC1基因)编码的CD59细胞表面抗原(旧称为S1抗原)。由于野生型AL细胞CD59基因正常表达时在细胞表面形成CD59抗原,在兔血清补体存在的情况下,该抗原与特异性抗体E7.1结合后,导致野生型细胞裂解而无法生存;而突变细胞因不能表达CD59蛋白,无法与抗体和补体作用而得以存活,在培养皿上形成肉眼可见的突变细胞克隆。根据这一特点,AL细胞已被广泛用于环境污染物如氡气、石棉、有机污染物、重金属等遗传毒性检测及相关机理研究。 Gene mutation is not only one of the key factors of cancer, but also an important basis for evaluating the genotoxicity of environmental pollutants. AL cells are immortalized cells obtained by crossing the gly - A mutant of Chinese hamster CHO cells with normal human fibroblasts, and contain a complete set of Chinese hamster CHO-K1 chromosomes and a human chromosome 11. Human chromosome 11 can encode a variety of cell surface proteins, including CD59 cell surface antigen (formerly known as S1 antigen) encoded by CD59 gene (formerly known as MIC1 gene). Due to the normal expression of the CD59 gene of wild-type A L cells, the CD59 antigen is formed on the cell surface. In the presence of rabbit serum complement, the antigen binds to the specific antibody E7.1, causing the wild-type cells to lyse and fail to survive; while the mutation The cells survived because they could not express CD59 protein and could not interact with antibodies and complements, and formed mutant cell clones visible to the naked eye on the culture dish. According to this feature, AL cells have been widely used in the detection of genotoxicity of environmental pollutants such as radon, asbestos, organic pollutants, heavy metals, and related mechanism research.

然而,在连续传代过程中,野生型AL细胞的自发突变细胞会不断增加,导致自发突变背景上升,基因突变检测的灵敏度下降,为了克服这一现象,在突变实验前,野生型AL细胞需采用Panning技术,除去CD59-的阴性细胞,以达到降低突变本底的目的。该过程具体如下: However, in the process of continuous passage, the spontaneous mutation cells of wild-type AL cells will continue to increase, resulting in an increase in the background of spontaneous mutations and a decrease in the sensitivity of gene mutation detection. In order to overcome this phenomenon, before the mutation experiment, wild-type AL cells Panning technology is required to remove CD59 - negative cells in order to reduce the mutation background. The process is as follows:

(1)山羊抗小鼠IgM处理普通平皿:10ml IgM/PBS(20μg/ml)IgM溶于PBS中)加入100mm普通平皿中,使其均匀的覆盖于皿底。室温,静止2小时。PBS清洗2次后,加入5ml1%FBS/PBS(1%小牛胎盘血清溶于PBS),黑暗中保存于4℃(可过夜); (1) Goat anti-mouse IgM treatment of ordinary plates: 10ml IgM/PBS (20μg/ml) IgM dissolved in PBS) added to 100mm ordinary plates, so that it evenly covers the bottom of the dish. Room temperature, let stand for 2 hours. After washing twice with PBS, add 5ml of 1% FBS/PBS (1% calf placenta serum dissolved in PBS), and store in the dark at 4°C (overnight);

(2)AL细胞收集:处于对数生长期的AL细胞酶解,悬浮于2%FBS/PBS(2%小牛胎盘血清溶于PBS)中。计数,离心,调整细胞密度至2×106/ml。细胞悬浮于含有0.2%CD59抗体的2%FBS/PBS中,冰浴30分钟。低温离心,预冷的2%FBS/PBS洗涤3次,并将细胞稀释至5×105/ml。 (2) AL cell collection: AL cells in logarithmic growth phase were hydrolyzed, suspended in 2% FBS/PBS (2% calf placental serum dissolved in PBS). Count, centrifuge, and adjust the cell density to 2×10 6 /ml. Cells were suspended in 2% FBS/PBS containing 0.2% CD59 antibody and kept on ice for 30 minutes. Centrifuge at low temperature, wash 3 times with pre-cooled 2% FBS/PBS, and dilute the cells to 5×10 5 /ml.

(3)细胞与山羊抗小鼠IgM相互作用:弃去平皿中1%FBS/PBS,将5ml悬浮于2%FBS/PBS中的细胞种植移入平皿。4℃孵育2小时。小心吸出上清夜,用预冷的2%FBS/PBS小心洗涤3次,除去没有贴壁的细胞和CD59-自发突变细胞。 (3) Interaction between cells and goat anti-mouse IgM: Discard 1% FBS/PBS in the plate, and plant 5ml of cells suspended in 2% FBS/PBS into the plate. Incubate at 4°C for 2 hours. Carefully aspirate the supernatant and wash carefully 3 times with pre-cooled 2% FBS/PBS to remove non-adherent cells and CD59 - spontaneous mutant cells.

(4)未突变细胞保存及检测:加入新鲜的F12完全培养液,连续培养3-4天,收集CD59+细胞,冻存于液氮。同时,需要对收集的细胞进行突变背景检测,这一过程需要14天。如果突变检测背景仍然偏高,需要重复上述步骤。一般情况下,细胞自发突变背景可降至每105 存活细胞中有70-80个突变细胞。由上可见,该方法操作过程繁琐,一个周期通常需要3周时间,特别是用IgM处理平皿和清洗突变细胞过程对实验操作人员技术的熟练程度有一定要求。同时,实验中所使用的特殊抗体—山羊抗小鼠IgM抗体价格较为昂贵,用量大。 (4) Preservation and detection of non-mutated cells: add fresh F12 complete culture medium, culture continuously for 3-4 days, collect CD59 + cells, and freeze them in liquid nitrogen. At the same time, the collected cells need to be tested for mutation background, which takes 14 days. If the mutation detection background is still high, the above steps need to be repeated. In general, the spontaneous mutation background of cells can be reduced to 70-80 mutant cells per 10 5 surviving cells. It can be seen from the above that the operation process of this method is cumbersome, and one cycle usually takes 3 weeks, especially the process of treating the plate with IgM and washing the mutant cells requires a certain degree of proficiency of the experimental operator. At the same time, the special antibody used in the experiment—goat anti-mouse IgM antibody is relatively expensive and used in large quantities.

发明内容 Contents of the invention

本发明的目的在于克服现有技术的不足,提供了一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法,基于流式细胞分选技术结合特异性荧光抗体,筛选突变及未突变细胞。 The purpose of the present invention is to overcome the deficiencies of the prior art and provide a method for reducing the background of spontaneous mutations in wild-type human-mouse hybridoma AL cells, based on flow cytometry technology combined with specific fluorescent antibodies to screen for mutations and non-mutations cell.

本发明是通过以下技术方案实现的,本发明包括以下步骤: The present invention is achieved through the following technical solutions, and the present invention comprises the following steps:

(1)野生型细胞收集 (1) Collection of wild-type cells

收取培养至对数生长期的AL细胞,酶解消化,悬浮于F12完全培养基中,清洗后制成浓度为±106细胞/100μl的单细胞悬液; Collect the AL cells cultured to the logarithmic growth phase, enzymatically digest, suspend in F12 complete medium, wash and make a single cell suspension with a concentration of ±10 6 cells/100 μl;

(2)与荧光抗体的结合 (2) Binding to fluorescent antibodies

加100μl预冷的流式细胞缓冲液重悬细胞后,按配比浓度加入荧光标记的CD59特异性抗体,4℃避光反应30~60分钟后,用预冷的FACS Buffer清洗离心,去除未结合的抗体; Add 100 μl of pre-cooled flow cytometry buffer to resuspend the cells, add fluorescently labeled CD59-specific antibody according to the proportioned concentration, and react in the dark at 4°C for 30-60 minutes, then wash and centrifuge with pre-cooled FACS Buffer to remove unbound cells. Antibodies;

(3)制备上样悬液 (3) Preparation of sample suspension

重悬细胞于预冷的流式细胞缓冲液后,送入流式细胞分选仪待测; After resuspending the cells in the pre-cooled flow cytometry buffer, send them to the flow cytometry sorter for testing;

(4)细胞分选 (4) Cell sorting

使用流式细胞分选仪进行分选; sorting using a flow cytometer;

(5)保存 (5) save

将分选获得的未突变细胞扩增,液氮保存。 The unmutated cells obtained by sorting were expanded and stored in liquid nitrogen.

所述细胞包括AL细胞、由该细胞发展的各种缺陷型细胞以及构建的细胞系。 The cells include AL cells, various defective cells developed from the cells, and constructed cell lines.

所述步骤(1)中,酶解消化所用的为胰蛋白酶,为质量含量为0.25%胰蛋白酶和0.02%EDTA溶于PBS缓冲液制得。 In the step (1), trypsin is used for enzymatic digestion, which is prepared by dissolving 0.25% trypsin and 0.02% EDTA in PBS buffer.

所述步骤(4)包括以下步骤: The step (4) includes the following steps:

a、建立前向散射FSC/侧向散射SSC散点图,通过初步设定门P1,排除死细胞和细胞碎片,找到目标细胞群; a. Establish a forward scatter FSC/side scatter SSC scatter diagram, and preliminarily set the gate P1 to exclude dead cells and cell debris, and find the target cell population;

b、建立SSC-W/FSC-W散点图,通过二次设定门P2,排除双联体细胞; b. Establish SSC-W/FSC-W scatter diagram, and exclude doublet cells by setting gate P2 twice;

c、建立PE-A/FSC-A荧光分析点图,根据对照细胞群位置设定阴阳性界定门,界定门以下为阴性CD59-细胞群,界定门以上为阳性CD59+细胞群。 c. Establish the PE-A/FSC-A fluorescence analysis point diagram, set the positive and negative gates according to the position of the control cell population, define negative CD59 - cell populations below the gate, and positive CD59 + cell populations above the gate.

所述分选获得的细胞用于连续培养,或者作为CD59基因流式检测突变技术中的阳性CD59+和阴性CD59-对照细胞 The cells obtained by the sorting are used for continuous culture, or as positive CD59 + and negative CD59 - control cells in CD59 gene flow cytometry detection mutation technology

本发明使用的AL细胞来源由THEODORE T.PUCK等在Genetics of Somatic Mammalian Cells: Lethal Antigens as Genetic Markers for Study of Human Linkage Groups中披露,Proc.Nat.Acad.Sci.USA Vol.68,No.12,pp.3102-3106,December1971。哺乳动物体细胞的遗传学:致命抗原作为遗传标记来研究人类连锁基因群。期刊Proc.Nat.Acad.Sci.全称为《美国国家科学院院刊》,简称PNAS。这篇文章发表于1971年11月PNAS杂志上第12期68卷,页码3102-3106。 The AL cell source used in the present invention is disclosed in Genetics of Somatic Mammalian Cells: Lethal Antigens as Genetic Markers for Study of Human Linkage Groups by THEODORE T.PUCK etc., Proc.Nat.Acad.Sci.USA Vol.68, No. 12, pp. 3102-3106, December 1971. Genetics of mammalian somatic cells: lethal antigens as genetic markers to study human linked gene groups. The full name of the journal Proc.Nat.Acad.Sci. is "Proceedings of the National Academy of Sciences of the United States", or PNAS for short. This article was published in the November 1971 issue of PNAS Magazine, Volume 12, Volume 68, Pages 3102-3106.

本发明相比现有技术具有以下优点: Compared with the prior art, the present invention has the following advantages:

1、本发明突变背景更低:一般通过传统的Panning技术本底突变值可降低至每105存活细胞中有70-80个突变(CD59-)细胞,而通过本方法,可进一步降低突变背景,达到每105存活细胞中约有30个突变细胞; 1. The mutation background of the present invention is lower: Generally, the background mutation value can be reduced to 70-80 mutant (CD59 - ) cells per 10 5 surviving cells through traditional Panning technology, and through this method, the mutation background can be further reduced , reaching about 30 mutant cells per 10 5 surviving cells;

2、效率高:一般传统方法步骤繁琐,细胞经过多步处理后丢失较多,上百万细胞经过抗体筛选得率仅为几万个细胞。而采用流式分选技术,检测量每秒最高可达1×104个细胞,分选数目每秒最高可达500个细胞,一小时内就可分选出上百万个CD59+细胞; 2. High efficiency: Generally, the steps of traditional methods are cumbersome, and many cells are lost after multi-step treatment, and the yield of millions of cells after antibody screening is only tens of thousands of cells. With flow sorting technology, the detection amount can reach up to 1×10 4 cells per second, and the sorting number can reach up to 500 cells per second, and millions of CD59 + cells can be sorted within one hour;

3、周期短:传统Panning技术整个过程比较繁琐,一个周期通常需要3周时间,特别是用IgM处理平皿和清洗突变细胞过程对实验操作人员技术的熟练程度有一定要求,本方法从收集细胞、与特异性荧光蛋白结合、分选,整个过程仅需4-5小时,简单快速且不易受实验环境条件的干扰,并可同时获得能连续培养的未突变(CD59+)细胞和突变(CD59-)细胞,这在很大程度上提高CD59基因突变检测的效率; 3. Short cycle: The whole process of traditional Panning technology is cumbersome, and a cycle usually takes 3 weeks, especially the process of treating the plate with IgM and cleaning the mutant cells has certain requirements for the proficiency of the experimental operator. This method starts from collecting cells, Combined with specific fluorescent protein and sorted, the whole process only takes 4-5 hours, simple, fast and not easily disturbed by experimental environmental conditions, and can simultaneously obtain non-mutated (CD59 + ) cells and mutant (CD59 - ) cells, which greatly improves the efficiency of CD59 gene mutation detection;

4、实验费用低:传统Panning技术中使用的山羊抗小鼠IgM抗体价格昂贵,抗体用量大,而本方法中使用的荧光抗体相对较为便宜,且每次实验用量非常少,在极大程度上节省了实验费用。 4. Low experimental cost: The goat anti-mouse IgM antibody used in the traditional Panning technique is expensive, and the amount of antibody used is large, while the fluorescent antibody used in this method is relatively cheap, and the amount of each experiment is very small, to a great extent Save experiment cost.

附图说明 Description of drawings

图1是FSC/SSC散点图; Figure 1 is the FSC/SSC scatter diagram;

图2是SSC-W/FSC-W散点图; Figure 2 is a scatter diagram of SSC-W/FSC-W;

图3是PE-A/FSC-A阴性细胞群荧光分析点图; Fig. 3 is the fluorescence analysis point diagram of PE-A/FSC-A negative cell group;

图4是PE-A/FSC-A阳性细胞群荧光分析点图; Fig. 4 is the fluorescence analysis point diagram of PE-A/FSC-A positive cell group;

图5是流式分选未突变AL细胞参数设置图; Fig. 5 is a flow cytometric sorting diagram of parameter settings for unmutated AL cells;

图6是克隆法检测流式分选前后AL细胞自发突变背景对比图; Figure 6 is a background comparison of AL cell spontaneous mutation before and after flow cytometry detection by cloning method;

图7是不同来源AL细胞自发突变率对比结果。 Figure 7 is a comparison of the spontaneous mutation rates of AL cells from different sources.

具体实施方式 Detailed ways

下面对本发明的实施例作详细说明,本实施例在以本发明技术方案为前提下进行实施,给出了详细的实施方式和具体的操作过程,但本发明的保护范围不限于下述的实施例。 The embodiments of the present invention are described in detail below. This embodiment is implemented on the premise of the technical solution of the present invention, and detailed implementation methods and specific operating procedures are provided, but the protection scope of the present invention is not limited to the following implementation example.

本实施例包括以下步骤: This embodiment includes the following steps:

(1)野生型细胞收集 (1) Collection of wild-type cells

收取培养至对数生长期的AL细胞,酶解消化,悬浮于F12完全培养基中,清洗后制成浓度为±106细胞/100μl的单细胞悬液; Collect the AL cells cultured to the logarithmic growth phase, enzymatically digest, suspend in F12 complete medium, wash and make a single cell suspension with a concentration of ±10 6 cells/100 μl;

(2)与荧光抗体的结合 (2) Binding to fluorescent antibodies

加100μl预冷的流式细胞缓冲液FACS Buffer重悬细胞后,按配比浓度加入荧光标记的CD59特异性抗体,4℃避光反应30~60分钟后,用预冷的FACS Buffer清洗离心,去除未结合的抗体;荧光抗体浓度:通常一个实验样本为±106细胞/100μl悬液,每100μl细胞悬液加10-20μl荧光抗体; Add 100 μl pre-cooled flow cytometry buffer FACS Buffer to resuspend the cells, add fluorescently labeled CD59-specific antibody according to the proportioned concentration, react in the dark at 4°C for 30-60 minutes, wash and centrifuge with pre-cooled FACS Buffer, remove Unbound antibody; fluorescent antibody concentration: usually an experimental sample is ±10 6 cells/100μl suspension, add 10-20μl fluorescent antibody per 100μl cell suspension;

(3)制备上样悬液 (3) Preparation of sample suspension

重悬细胞于预冷的FACS Buffer后,FACS Buffer是流式细胞缓冲液,配方为:质量比为1%的牛血清白蛋白,10mM叠氮钠溶解于磷酸盐缓冲液PBS(含有钙和镁离子,pH=7.0),送入流式细胞分选仪待测; After resuspending cells in pre-cooled FACS Buffer, FACS Buffer is a flow cytometry buffer, the formula is: bovine serum albumin with a mass ratio of 1%, 10mM sodium azide dissolved in phosphate buffered saline PBS (containing calcium and magnesium ions, pH=7.0), sent to the flow cytometer for testing;

(4)细胞分选 (4) Cell sorting

使用流式细胞分选仪进行分选;细胞分选采用的仪器为BD FACS AriaTMⅢCell Sorter; Sorting was performed using a flow cytometer; the instrument used for cell sorting was BD FACS Aria TM III Cell Sorter;

a、如图1所示,在流式细胞仪上获取数据时,建立前向散射FSC/侧向散射SSC散点图,SSC用来检测细胞内部颗粒度,FSC用来检测细胞的大小。通过初步设定门P1,排除死细胞和细胞碎片,找到目标细胞群,并调节各个光电倍增管装置以确定所有要分析的细胞群都在点图的可视范围内。具体如下:通过设置和调节FSC阈值,将大部分的细胞碎片、气泡和激光背景噪的干扰排除在分析区域之外(都应该设在FSC-low/SSC-low区域),接下来在FSC/SSC点图中圈出目标细胞群的周围区域(P1),这个区域可以被称为“P1-FSC/SSC”,P1设门主要是根据细胞最集中的部分圈定其范围,排除周围过大过小的分散的细胞颗粒或碎片杂质; a. As shown in Figure 1, when acquiring data on the flow cytometer, establish a forward scatter FSC/side scatter SSC scatter diagram, SSC is used to detect the particle size inside the cell, and FSC is used to detect the size of the cell. By initially setting the gate P1, excluding dead cells and cell debris, finding the target cell population, and adjusting each photomultiplier device to ensure that all the cell populations to be analyzed are within the visible range of the dot plot. The details are as follows: By setting and adjusting the FSC threshold, most of the cell debris, air bubbles and laser background noise are excluded from the analysis area (all should be set in the FSC-low/SSC-low area), and then in the FSC/ The surrounding area (P1) of the target cell group is circled in the SSC dot diagram. This area can be called "P1-FSC/SSC". Small dispersed cell particles or debris impurities;

b、建立SSC-W/FSC-W散点图,通过二次设定门P2,排除双联体细胞,保证最后进行荧光检测和分选的细胞是单个细胞,如图2所示,W指收集信号的宽度。SSC-W/FSC-W全称为侧向散射角-宽度/前向散射角-宽度散点图。宽度(如SSC-W)常用来区分双联体细胞。由于双联体细胞所得到的信号会比单个细胞大,反应在SSC-W/FSC-W图上即为纵坐标和横坐标值较大较离散的点状区域,因此根据细胞的大小和颗粒度的宽度二次设门P2来排除双联体; b. Establish the SSC-W/FSC-W scatter diagram, and exclude the doublet cells by setting the gate P2 twice to ensure that the final fluorescent detection and sorting cells are single cells, as shown in Figure 2, W means The width of the collected signal. SSC-W/FSC-W stands for Side Scatter Angle-Width/Forward Scatter Angle-Width Scatter Plot. Width (such as SSC-W) is often used to distinguish doublet cells. Since the signal obtained by the doublet cell will be larger than that of a single cell, the reaction on the SSC-W/FSC-W diagram is a point-like area with large vertical and horizontal coordinates, so according to the size of the cell and the size of the particle The width of the degree is set gate P2 twice to exclude doublets;

c、建立PE-A/FSC-A荧光分析点图,如图3和图4所示,根据对照细胞群位置设定阴阳性界定门,界定门以下为阴性CD59-细胞群,界定门以上为阳性CD59+细胞群,图3中界定门以下Q4区为阴性(CD59-)细胞群,图4中界定门以上Q2区为阳性(CD59+)细胞群,这两群细胞中必然包含一些假阳性/假阴性的细胞或杂质,可通过精确调节界定门以上或以下的 分选区域,以及调节分选模式来获得高纯度的阳性和阴性对照细胞,PE为抗体偶联的染料-藻红蛋白;A为荧光脉冲的面积,面积积分比荧光脉冲的高度H更能准确反应检测指标的含量。PE-A/FSC-A全称为荧光染料-荧光脉冲面积/细胞大小-荧光脉冲面积分析点图。 c. Establish the PE-A/FSC-A fluorescence analysis point map, as shown in Figure 3 and Figure 4, set the negative and positive limit gates according to the position of the control cell population, the negative CD59 - cell population is defined below the gate, and the negative CD59- cell population is defined above the gate. Positive CD59 + cell population, the Q4 area below the gate is defined as negative (CD59 - ) cell population in Figure 3, and the Q2 area above the gate is defined as positive (CD59 + ) cell population in Figure 4, these two populations of cells must contain some false positives /False-negative cells or impurities can be obtained by precisely adjusting the sorting area defined above or below the gate, and adjusting the sorting mode to obtain high-purity positive and negative control cells. PE is an antibody-coupled dye-phycoerythrin; A is the area of the fluorescence pulse, and the area integral can more accurately reflect the content of the detection index than the height H of the fluorescence pulse. The full name of PE-A/FSC-A is fluorescent dye-fluorescence pulse area/cell size-fluorescence pulse area analysis dot plot.

阴阳性界定门是根据阳性和阴性对照细胞群分别占收集细胞的百分比划分的,通过设置和调节PE对应的FL2荧光通道的电压值和四象限门位置,使检测到的阳性和阴性细胞纯度都分别达到99.9%及以上,这时对应的象限门位置就是划分阴阳性对照细胞的界定门。 The positive and negative control gates are divided according to the percentages of the positive and negative control cell populations in the collected cells. By setting and adjusting the voltage value of the FL2 fluorescence channel corresponding to PE and the position of the four-quadrant gate, the purity of the detected positive and negative cells is equal. Reaching 99.9% and above respectively, at this time the corresponding quadrant gate position is the defining gate for dividing negative and positive control cells.

图5表示通过分选获得低突变背景的CD59+细胞,图中根据对照细胞设定的界定门(虚线所示)以上Q2部分为CD59+的阳性细胞群,界定门以下Q4部分为CD59-的阴性细胞群。Q2部分均可作为分选区域,通过调节界定门位置和设门区域(箭头和方框所示)进一步提高分选纯度。图中P3部分即为最终分选的细胞群。 Figure 5 shows the CD59 + cells with low mutation background obtained by sorting. In the figure, the Q2 part above the defined gate (shown by the dotted line) set by the control cells is the CD59 + positive cell population, and the Q4 part below the defined gate is the CD59- positive cell population. Negative cell population. The Q2 part can be used as a sorting area, and the sorting purity can be further improved by adjusting the position of the defined gate and the area of the gate (shown by the arrow and the box). Part P3 in the figure is the final sorted cell population.

(5)保存 (5) save

将分选获得的未突变细胞扩增,液氮保存。 The unmutated cells obtained by sorting were expanded and stored in liquid nitrogen.

如图6所示,对于本实施例分选后的AL细胞,通过克隆法检测流式分选前后AL细胞自发突变背景,左边为分选前的AL细胞,右边为分选后的AL细胞,从由图中可以看出,流式分选可显著降低本底突变数目。 As shown in Figure 6, for the AL cells after sorting in this embodiment, the spontaneous mutation background of AL cells before and after flow cytometry sorting was detected by cloning method, the left side is the AL cells before sorting, and the right side is the sorted AL cells AL cells, as can be seen from the figure, flow sorting can significantly reduce the number of background mutations.

克隆法检测原理为:野生型AL细胞CD59基因正常表达时在细胞表面形成CD59抗原,在兔血清补体存在的情况下,该抗原与特异性抗体E7.1结合后,导致野生型细胞裂解而无法生存;而突变细胞因不能表达CD59蛋白,无法与抗体和补体作用而得以存活,在培养皿上形成肉眼可见的突变细胞克隆。 The detection principle of the cloning method is: when the CD59 gene of wild-type A L cells is normally expressed, the CD59 antigen is formed on the cell surface, and in the presence of rabbit serum complement, the antigen binds to the specific antibody E7.1, resulting in the lysis of the wild-type cells Can not survive; mutant cells cannot survive because they cannot express CD59 protein and cannot interact with antibodies and complements, forming mutant cell clones visible to the naked eye on the culture dish.

具体过程:  Specific process:

1、将处理后细胞重新连续培养7-14天,使处理后的存活细胞有足够的时间从生长暂时停滞状态中恢复,同时,也使突变细胞繁殖的后代细胞表面不再残留CD59抗原: 1. Re-cultivate the treated cells continuously for 7-14 days, so that the surviving cells after treatment have enough time to recover from the temporary stagnation of growth, and at the same time, the CD59 antigen will no longer remain on the surface of the progeny of the mutant cells:

2、加抗体补体与CD59抗原相互作用并连续培养7至10天,直至形成肉眼可见克隆,弃去培养液,固定,Giemsa染色,计算存活细胞的克隆数; 2. Add antibody complement to interact with CD59 antigen and continue to culture for 7 to 10 days until visible clones are formed, discard the culture medium, fix, Giemsa staining, and calculate the number of clones of surviving cells;

3、统计突变细胞克隆数,计算细胞突变率。细胞突变率=突变细胞的克隆数/校准后每1×105存活的细胞数。 3. Count the number of mutant cell clones and calculate the cell mutation rate. Cell mutation rate = clone number of mutant cells/number of surviving cells per 1×10 5 after calibration.

图7是对不同来源AL细胞自发突变率进行对比的结果。野生型AL细胞为124/105cells;通过Panning技术,AL细胞自发突变率可降至80/105cells,而流式分选技术更进一步降低突变背景,达30/105cells。 Figure 7 is the result of comparing the spontaneous mutation rate of AL cells from different sources. The wild-type AL cells are 124/10 5 cells; through Panning technology, the spontaneous mutation rate of AL cells can be reduced to 80/10 5 cells, and the flow sorting technology further reduces the mutation background to 30/10 5 cells.

Claims (4)

1.一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法,其特征在于,包括以下步骤:1. A method for reducing the spontaneous mutation background of wild-type human mouse hybridoma AL cells, characterized in that, comprising the following steps: (1)野生型细胞收集(1) Collection of wild-type cells 收取培养至对数生长期的细胞,酶解消化,悬浮于F12完全培养基中,清洗后制成浓度为±106细胞/100μl的单细胞悬液;Cells cultured to logarithmic growth phase were harvested, enzymatically digested, suspended in F12 complete medium, washed and made into a single cell suspension with a concentration of ±10 6 cells/100 μl; (2)与荧光抗体的结合(2) Binding to fluorescent antibodies 加100μl预冷的流式细胞缓冲液重悬细胞后,按配比浓度加入荧光标记的CD59特异性抗体,4℃避光反应30~60分钟后,用预冷的FACS Buffer清洗离心,去除未结合的抗体;Add 100 μl of pre-cooled flow cytometry buffer to resuspend the cells, add fluorescently labeled CD59-specific antibody according to the proportioned concentration, and react in the dark at 4°C for 30-60 minutes, then wash and centrifuge with pre-cooled FACS Buffer to remove unbound cells. Antibodies; (3)制备上样悬液(3) Preparation of sample suspension 重悬细胞于预冷的流式细胞缓冲液后,送入流式细胞分选仪待测;After resuspending the cells in the pre-cooled flow cytometry buffer, send them to the flow cytometry sorter for testing; (4)细胞分选(4) Cell sorting 使用流式细胞分选仪进行分选;sorting using a flow cytometer; (5)保存(5) save 将分选获得的未突变细胞扩增,液氮保存;所述细胞包括AL细胞、由该细胞发展的各种缺陷型细胞以及构建的细胞系。The unmutated cells obtained by sorting are expanded and stored in liquid nitrogen; the cells include AL cells, various defective cells developed from the cells, and cell lines constructed. 2.根据权利要求1所述的一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法,其特征在于,所述步骤(1)中,酶解消化所用的酶为胰蛋白酶,酶解消化所用缓冲液为质量含量为0.25%胰蛋白酶和0.02%EDTA的PBS缓冲液。2. a kind of method that reduces wild-type human mouse hybridoma AL cell spontaneous mutation background according to claim 1, is characterized in that, in described step (1), the enzyme used for enzymatic digestion is trypsin, enzyme The buffer used for digestion is PBS buffer with a mass content of 0.25% trypsin and 0.02% EDTA. 3.根据权利要求1所述的一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法,其特征在于,所述步骤(4)包括以下步骤:3. a kind of method that reduces wild-type human mouse hybridoma AL cell spontaneous mutation background according to claim 1, is characterized in that, described step (4) comprises the following steps: a、建立前向散射FSC/侧向散射SSC散点图,通过初步设定门P1,排除死细胞和细胞碎片,找到目标细胞群;a. Establish a forward scatter FSC/side scatter SSC scatter diagram, and preliminarily set the gate P1 to exclude dead cells and cell debris, and find the target cell population; b、建立SSC-W/FSC-W散点图,通过二次设定门P2,排除双联体细胞;b. Establish SSC-W/FSC-W scatter diagram, and exclude doublet cells by setting gate P2 twice; c、建立PE-A/FSC-A荧光分析点图,根据对照细胞群位置设定阴阳性界定门,界定门以下为阴性CD59-细胞群,界定门以上为阳性CD59+细胞群。c. Establish the PE-A/FSC-A fluorescence analysis point diagram, set the positive and negative gates according to the position of the control cell population, define negative CD59 - cell populations below the gate, and positive CD59 + cell populations above the gate. 4.根据权利要求1所述的一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法,其特征在于,所述分选获得的细胞用于连续培养,或者作为CD59基因流式检测突变技术中的阳性CD59+和阴性CD59-对照细胞。4. A method for reducing the background of spontaneous mutations in wild-type human mouse hybridoma AL cells according to claim 1, wherein the cells obtained by the sorting are used for continuous culture, or as CD59 gene flow detection Positive CD59 + and negative CD59- control cells in the mutagenesis technique.
CN201310419228.XA 2013-09-13 2013-09-13 A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells Active CN103529202B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310419228.XA CN103529202B (en) 2013-09-13 2013-09-13 A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310419228.XA CN103529202B (en) 2013-09-13 2013-09-13 A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells

Publications (2)

Publication Number Publication Date
CN103529202A CN103529202A (en) 2014-01-22
CN103529202B true CN103529202B (en) 2015-04-15

Family

ID=49931380

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310419228.XA Active CN103529202B (en) 2013-09-13 2013-09-13 A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells

Country Status (1)

Country Link
CN (1) CN103529202B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108486212B (en) * 2018-04-28 2022-03-04 中国科学院合肥物质科学研究院 A method for antagonizing the biological toxicity of heavy metal arsenic

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102783416A (en) * 2012-07-25 2012-11-21 陕西天正达生物科技股份有限公司 Breeding method for resistant super-male polyploidy asparagus based on flow cytometry
CN103215352A (en) * 2013-03-29 2013-07-24 中国医学科学院血液病医院(血液学研究所) Assay kit for detecting stimulated emission depletion 2 (STED 2) gene mutation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754155B2 (en) * 2002-03-15 2010-07-13 Ross Amelia A Devices and methods for isolating target cells
BRPI0607486B8 (en) * 2005-03-03 2021-05-25 Immunomedics Inc 1243 humanized antibody against hla-dr present in hladr+ cells, pharmaceutical composition, kit and use of said antibodies.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102783416A (en) * 2012-07-25 2012-11-21 陕西天正达生物科技股份有限公司 Breeding method for resistant super-male polyploidy asparagus based on flow cytometry
CN103215352A (en) * 2013-03-29 2013-07-24 中国医学科学院血液病医院(血液学研究所) Assay kit for detecting stimulated emission depletion 2 (STED 2) gene mutation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
梁喆等.人-鼠及人-(人-鼠)杂交瘤中染色体行为与杂交瘤稳定性的关系.《第四军医大学学报》.1993,第14卷(第1期),53-57. *
青石棉诱导AL细胞CD59基因突变和DNA氧化损伤的研究;许安等;《中华劳动卫生职业病杂志》;20040229;第22卷(第1期);43-46 *

Also Published As

Publication number Publication date
CN103529202A (en) 2014-01-22

Similar Documents

Publication Publication Date Title
Guilliams et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
Olsen et al. The anatomy of single cell mass cytometry data
Partlová et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
Yang et al. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells
Braasch et al. The changing dielectric properties of CHO cells can be used to determine early apoptotic events in a bioprocess
CN105067808A (en) High-purity circulation tumor cell enriching method and kit
Amoli et al. EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood
CN106834271A (en) A kind of high-throughput screening method of deletion mutant
Hamot et al. Method validation for automated isolation of viable peripheral blood mononuclear cells
EP2972359A1 (en) Enrichment of circulating tumor cells by depleting white blood cells
Gallagher et al. Selection of high-producing clones using FACS for CHO cell line development
Li et al. Detection of carcinoma in serous effusions: a review
González-González et al. Elimination of contaminants from cell preparations using aqueous two-phase partitioning
CN103529202B (en) A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells
CN112945667B (en) Preparation method of blood single-cell suspension for removing nucleated red blood cells
Carroll et al. ACSD labelling and magnetic cell separation: a rapid method of separating antibody secreting cells from non-secreting cells
Assenmacher et al. Detection and isolation of cytokine secreting cells using the cytometric cytokine secretion assay
Dong et al. DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer
Kumpel et al. Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated from human placenta
Yano et al. DNA extraction for short tandem repeat typing from mixed samples using anti-human leukocyte CD45 and ABO blood group antibodies
Gole et al. Modified cIg-FISH protocol for multiple myeloma in routine cytogenetic laboratory practice
CN116879142A (en) Method for counting CD34-positive cells in hematopoietic stem cells
CN117844759A (en) Method for stimulating CAR-T cells by protein magnetic bead coupling simulated tumor cells
LudueñA et al. Expression of liver and placental alkaline phosphatases in Chang liver cells
Wing et al. An improved method for the detection of cell surface antigens in samples of low viability using flow cytometry

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant